Mitsubishi Tanabe Pharma

Pharma

Astellas, Mitsubishi Tanabe, Leqembi—Fierce Pharma Asia

Astellas reprioritizes its investment focus. Bain buys Mitsubishi Tanabe for $3.3 billion. Eisai sees an upcoming Leqembi "expansion phase." And more.

Angus Liu Feb 14, 2025 9:51am

Bain Capital lays out $3.3B to acquire Mitsubishi Tanabe Pharma

Feb 7, 2025 11:26am

A $410M obesity debut, Legend, BeiGene and more—Fierce Pharma Asia

Jan 10, 2025 9:00am

Merck's GLP-1 play; Astellas' AAV deal—Fierce Pharma Asia

Dec 20, 2024 8:51am

Sanofi, GSK and China reimbursement updates—Fierce Pharma Asia

Dec 6, 2024 9:00am

FDA snubs AbbVie's blockbuster-to-be Parkinson's drug

Mar 22, 2023 11:50am